Keith Sorgius

Keith Sorgius has a diverse work experience. Keith began their career at Charles Schwab in 2011 as an Asset Management Operations-Dividends role, where they worked until 2015. Keith then joined TIAA as a Sr. Analyst, Brokerage Operations from 2015 to 2019. Currently, they are working at RxBenefits, Inc. as a Strategic Pharmacy Analyst since March 2019 and was promoted to Strategic Account Executive in August 2021.

Keith Sorgius attended Indiana University Bloomington from 2005 to 2009, where they completed a Bachelor of Sciences in Business with a focus on Finance/Real Estate. In 2008, they also had the opportunity to study abroad at the University of Sydney, further expanding their knowledge in Finance.